Clinical Trials in Michigan

Showing 4061-4080 of 16,154 trials

QTX3046 in Patients With KRAS G12D Mutations

NCT06428500

Phase 1 study to determine the safety and tolerability of QTX3046 as a single agent or in combination with cetuximab.

Quanta Therapeutics240 participantsStarted May 2024

Grand Rapids, Michigan, United States • Durham, North Carolina, United States • Houston, Texas, United States +2 more locations

COMPLETED79 miles

Development and Validation of Harbinger Health Test for Early Cancer Detection

NCT05435066

This is a prospective, multi-center, observational study with a collection of biospecimens and clinical data from approximately 10,000 participants from up to 125 clinical network sites and locations in the United States. The objective of this study is to collect blood samples, tissue samples, and associated clinical data from participants with a variety of solid tumor and hematologic cancers and non-cancer participants for testing and the development of a screening test for early cancer detection.

Cancer

Harbinger Health8,038 participantsStarted Jun 2022

Daphne, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +125 more locations

QTX3046 in Patients With KRAS G12D Mutations

Development and Validation of Harbinger Health Test for Early Cancer Detection

Find Trials by Condition in Michigan

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

International CIPN Assessment and Validation Study

Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone Study

Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

A Study to Evaluate EDP 938 Regimens in Children With RSV

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

A Long-term Follow-up Study of Patients Who Received VOR33

A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD